XML 42 R30.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity (Tables)
3 Months Ended
Sep. 30, 2025
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended September 30, 

    

2024

    

2025

Cost of goods sold

$

244

$

285

Selling, general and administrative

6,024

5,753

Research and development

154

161

Stock-based compensation expense

$

6,422

$

6,199

Schedule of stock option activity

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2025

 

60,253

 

$

121.41

 

Granted

 

Exercised

 

(2,215)

98.27

Expired or forfeited

 

Outstanding at September 30, 2025

 

58,038

$

122.29

7.7 years

$

7,368

Exercisable at September 30, 2025

20,387

$

95.92

 

6.5 years

$

3,126

Summary of RSU award activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2025

 

355,396

$

116.34

Granted

 

213,773

223.88

Vested

 

(313,580)

165.91

Forfeited

 

(1,507)

110.42

Nonvested at September 30, 2025

 

254,082

$

145.67